Medline Inc.
MDLN- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0002046386
In the last 90 days, Medline Inc. insiders filed 0 open-market purchases and 3 sales; 412 institutions reported holding it in 13F filings for Q2 2026, worth $33.7B in total; 3 superinvestors hold it, including Lone Pine Capital and Viking Global Investors.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.05B in total
- 3
- 13F holdersQ2 2026, +96 vs. previous quarter
- 412
- 13F valueReported value at the end of Q2 2026
- $33.7B
- Superinvestors holdingAt the end of Q2 2026
- 3
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $28.4B
- No comparable prior period
- Net income, FY2025
- $1.16B
- No comparable prior period
- Free cash flow, FY2025
- $1.30B
- No comparable prior period
- Revenue, Q3 FY2026
- $7.86B
- No comparable prior period
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 40.8M
- Shares sold short
- Change
- −11.9M
- −22.5% vs. previous
- Days to cover
- 5.38
- At average daily volume
Superinvestors holding MDLN, Q2 2026
Go to the superinvestors tab3 superinvestors report holding Medline Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Lone Pine Capital
Stephen Mandel
5.1%
Medline Inc.'s share of the portfolio
- Shares
- 20,968,367
- Value
- $827.0M
Viking Global Investors
Andreas Halvorsen
0.5%
Medline Inc.'s share of the portfolio
- Shares
- 4,841,080
- Value
- $190.9M
| Superinvestor | Weight | Value |
|---|---|---|
| Soros Fund Management | 0.8% | $64.6M |
Latest insider trades
See all insider tradesOpen-market purchases and sales by Medline Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 (view filing)9:25 AM ET | Oct 8 | 5 days | GIC Private Ltd and 2 others10% Owner | SSaleClass A Common Stock | −7.82M | $35.15 | −$274.8M | −10.1%69.4M after | |
| Oct 6, 2026 (view filing)9:48 PM ET | Oct 2-6 | 4 days | GIC Private Ltd and 2 others10% Owner | SSaleClass A Common Stock | −6.35M | $35.37 | −$224.5M | −27.8%16.5M after | 3 lots |
| Oct 6, 2026 (view filing)9:48 PM ET | Oct 2-6 | 4 days | GIC Private Ltd and 2 others10% Owner | SSaleClass A Common Stock | −14.3M | $34.69 | −$497.1M | −15.7%77.2M after | 2 lots |
| Aug 17, 2026 (view filing)4:15 PM ET | Aug 13-14 | 4 days | GIC Private Ltd and 2 others10% Owner | SSaleClass A Common Stock | −1.60M | $35.80 | −$57.3M | −6.6%22.8M after | 2 lots |
| Aug 11, 2026 (view filing)9:03 AM ET | Aug 7 | 4 days | GIC Private Ltd and 2 others10% Owner | SSaleClass A Common Stock | −590.3K | $35.58 | −$21.0M | −2.4%24.4M after | |
| Aug 7, 2026 (view filing)4:15 PM ET | Aug 5-6 | 2 days | GIC Private Ltd and 2 others10% Owner | SSaleClass A Common Stock | −2.25M | $35.56 | −$80.0M | −8.3%25.0M after | 3 lots |
| Jun 17, 2026 (view filing) | Jun 16 | 1 day | Golwas Douglas PChief Commercial Officer | SSaleClass A Common Stock | −100.0K | $36.77 | −$3.68M | −80.7%23.9K after | 2 lots10b5-1 |
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Corcoran Jessi LPrincipal Accounting Officer | PPurchaseClass A Common Stock | +5.00K | $34.15 | +$170.8K | New position5.00K after | |
| Jun 1, 2026 (view filing)6:16 PM ET | May 28 | 4 days | HFCP X (Parallel-A), L.P. and 8 others10% Owner | SSaleClass A Common Stock | −31.9M | $36.54 | −$1.16B | −83.0%6.52M after | 4 lots |
| Jun 1, 2026 (view filing)4:15 PM ET | May 28 | 4 days | Schwarzman Stephen A and 6 others10% Owner | SSaleClass A Common Stock | −33.3M | $36.54 | −$1.22B | −100.0%1.54K after | 4 lotsDuplicate filing |
Top 10 13F holders, Q2 2026
See all 412 holdersThe largest institutional positions in Medline Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 187,083,713 | $7.38B | 73.78% | 00.0% | Unchanged |
| Blackstone Group Inc. | 101,791,008 | $4.01B | 10.96% | −22,407,340−18.0% | Reduced |
| H&F Corporate Investors X, Ltd. | 70,874,326 | $2.80B | 100.00% | −15,599,171−18.0% | Reduced |
| FMR LLC | 46,963,203 | $1.85B | 0.08% | +10,407,002+28.5% | Added |
| Capital Research Global Investors | 39,963,790 | $1.58B | 0.22% | +16,802,120+72.5% | Added |
| Invesco Ltd. | 38,346,937 | $1.51B | 0.12% | +17,383,322+82.9% | Added |
| BlackRock, Inc. | 26,393,587 | $1.04B | 0.02% | +9,469,927+56.0% | Added |
| Morgan Stanley | 21,605,662 | $852.1M | 0.05% | +5,902,759+37.6% | Added |
| Lone Pine Capital LLCSuperinvestorLone Pine Capital | 20,968,367 | $827.0M | 5.06% | +9,179,211+77.9% | Added |
| Massachusetts Financial Services Co | 19,888,806 | $787.1M | 0.25% | +8,319,490+71.9% | Added |
Holders of 5% or more of MDLN
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Medline Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Mozart Holdco, Inc. | 13G | 22.40%234.3M shares | New | Feb 13, 20261 filing | Feb 13, 2026 | SEC |
| Carlyle Group Inc. | 13G/A | 20.60%187.1M shares | −3.80 ppfrom 24.40% | Feb 13, 20262 filings | May 15, 2026 | SEC |
| Blackstone Holdings II L.P. | 13G/A | 16.50%153.3M shares | −4.10 ppfrom 20.60% | Feb 13, 20263 filings | Aug 7, 2026 | SEC |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | 13G/A | 16.00%153.3M shares | −3.80 ppfrom 19.80% | Feb 13, 20263 filings | Aug 11, 2026 | SEC |
| GIC Private Ltd | 13G/A | 8.49%74.6M shares | −4.54 ppfrom 13.03% | Dec 29, 20253 filings | Nov 6, 2026 | SEC |